Tony Richardson is CEO of Venn Life Sciences an integrated drug development company supporting companies through the drug development, clinical design, and execution process. With a global perspective, entrepreneurial minded Richardson works with investors and partners to continual grow and expand the business both organically and via M&A. He has over 16 years’ experience in the Life Sciences Sector and has held key leadership positions in several Medical Technology companies. He has considerable transaction experience including IPO, financings, and M&A at a European level. Tony is a Fellow of the Chartered Association of Certified Accountants and is an alumnus of Stanford University where he completed he Enterprise Ireland ‘Leadership for Growth’ executive program.
In 2010 he assumed the role of CEO and in that year, Venn completed two acquisitions that provide the basis for the current business. A further acquisition in 2015 enabled the company to extend their services to include early phase drug development consultancy. The business has grown considerably in that time with offices in Ireland, Northern Ireland, France, Germany, and the Netherlands including international partnerships. At the 2016 Ireland France Business awards with Enterprise Ireland Venn was awarded Best Irish company in France which was a huge tribute to the Venn team.
Tony is a keen cyclist and runner something he seems to share with wider Venn community who participate in various sporting events throughout the year. So, a very nice way to connect personally with staff across all departments and locations.